^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

NM-301

i
Other names: NM-301, AST-301
News
Trials
Company:
Aptamer Sci, Neuramedy
Drug class:
TLR2 antagonist
Related drugs:
News
Trials